Citius Pharmaceuticals Inc (CTXR) is higher by 1.97% Thursday In Premarket Trading

Citius Pharmaceuticals Inc (CTXR) has gained Thursday morning, with the stock increasing 1.97% in pre-market trading to 2.07. CTXR's short-term technical score of 39 indicates that the stock has traded less bullishly over the last month than 61% of stocks on the market. In the Biotechnology industry, which ranks 134 out of 146 industries, CTXR ranks higher than 68% of stocks. Citius Pharmaceuticals Inc has fallen 3.33% over the past month, closing at $2.10 on September 9. During this period of time, the stock fell as low as $1.95 and as high as $2.20. CTXR has an average analyst recommendation of Strong Buy. The company has an average price target of $7.00.

CTXR has an Overall Score of 52. Find out what this means to you and get the rest of the rankings on CTXR!

See Full CTXR Report

Citius Pharmaceuticals Inc has a Long-Term Technical rank of 34. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 66% of the market scoring higher. In the Biotechnology industry which is number 134 by this metric, CTXR ranks better than 62% of stocks.

Important Dates for Investors in CTXR:

-Citius Pharmaceuticals Inc is set to release earnings on 11/10/2021. During their last earnings release the company posted EPS of $-0.31. -We do not have a set dividend date for Citius Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Citius Pharmaceuticals Inc (CTXR)